🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
Last 3 Months
›
Healthcare Sector
Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(5662)
All (5662)
Buys (603)
Sells (5059)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
Monte Rosa Therapeutics, Inc.
(GLUE)
Manning Anthony M.
— Director
May 21, 2026
Sale
Shares
10,000
Price
$18.01
Total Value
$180.10K
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Kura Oncology, Inc.
(KURA)
Powl Brian T.
— Chief Commercial Officer
May 21, 2026
Sale
Shares
10,000
Price
$11.00
Total Value
$110.00K
Shares Held After
173,614
% of Holdings
5.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
NATIONAL HEALTHCARE CORP
(NHC)
LAROCHE RICHARD F JR
— Director
May 21, 2026
Sale
Shares
7,500
Price
$195.14
Total Value
$1.46M
Shares Held After
205,760
% of Holdings
3.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ARDELYX, INC.
(ARDX)
RAAB MICHAEL
— Director
May 21, 2026
Sale
Shares
14,028
Price
$6.27
Total Value
$87.92K
Shares Held After
1,720,033
% of Holdings
0.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ARDELYX, INC.
(ARDX)
RAAB MICHAEL
— Director
May 21, 2026
Sale
Shares
17,926
Price
$6.27
Total Value
$112.35K
Shares Held After
1,734,061
% of Holdings
1.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ARDELYX, INC.
(ARDX)
RAAB MICHAEL
— Director
May 21, 2026
Sale
Shares
7,861
Price
$6.27
Total Value
$49.27K
Shares Held After
1,751,987
% of Holdings
0.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ARDELYX, INC.
(ARDX)
RAAB MICHAEL
— Director
May 21, 2026
Sale
Shares
14,933
Price
$6.27
Total Value
$93.59K
Shares Held After
1,759,848
% of Holdings
0.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ARDELYX, INC.
(ARDX)
Williams Laura A
— Chief Patient Officer
May 21, 2026
Sale
Shares
1,418
Price
$6.27
Total Value
$8.89K
Shares Held After
429,093
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ARDELYX, INC.
(ARDX)
Williams Laura A
— Chief Patient Officer
May 21, 2026
Sale
Shares
1,911
Price
$6.27
Total Value
$11.98K
Shares Held After
430,511
% of Holdings
0.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ARDELYX, INC.
(ARDX)
Williams Laura A
— Chief Patient Officer
May 21, 2026
Sale
Shares
2,157
Price
$6.27
Total Value
$13.52K
Shares Held After
432,422
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ARDELYX, INC.
(ARDX)
Williams Laura A
— Chief Patient Officer
May 21, 2026
Sale
Shares
1,503
Price
$6.27
Total Value
$9.42K
Shares Held After
434,579
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BIOLIFE SOLUTIONS INC
(BLFS)
Casdin Partners Master Fund, L.P.
— 10% Owner
May 21, 2026
Sale
Shares
650,000
Price
$23.70
Total Value
$15.40M
Shares Held After
4,757,165
% of Holdings
12.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CVS HEALTH Corp
(CVS)
ROBBINS LARRY
— Director
May 21, 2026
Sale
Shares
370,462
Price
$93.45
Total Value
$34.62M
Shares Held After
4,824,799
% of Holdings
7.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
MAHON PAUL A
— EVP & GENERAL COUNSEL
May 21, 2026
Sale
Shares
300
Price
$562.50
Total Value
$168.75K
Shares Held After
45,172
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
MAHON PAUL A
— EVP & GENERAL COUNSEL
May 21, 2026
Sale
Shares
270
Price
$566.05
Total Value
$152.83K
Shares Held After
45,472
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
MAHON PAUL A
— EVP & GENERAL COUNSEL
May 21, 2026
Sale
Shares
1,251
Price
$565.20
Total Value
$707.06K
Shares Held After
45,742
% of Holdings
2.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
MAHON PAUL A
— EVP & GENERAL COUNSEL
May 21, 2026
Sale
Shares
2,015
Price
$564.06
Total Value
$1.14M
Shares Held After
46,993
% of Holdings
4.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
MAHON PAUL A
— EVP & GENERAL COUNSEL
May 21, 2026
Sale
Shares
1,326
Price
$562.93
Total Value
$746.45K
Shares Held After
49,008
% of Holdings
2.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
MAHON PAUL A
— EVP & GENERAL COUNSEL
May 21, 2026
Sale
Shares
2,178
Price
$561.99
Total Value
$1.22M
Shares Held After
50,334
% of Holdings
4.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
MAHON PAUL A
— EVP & GENERAL COUNSEL
May 21, 2026
Sale
Shares
200
Price
$559.99
Total Value
$112.00K
Shares Held After
52,512
% of Holdings
0.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
MAHON PAUL A
— EVP & GENERAL COUNSEL
May 21, 2026
Sale
Shares
640
Price
$557.85
Total Value
$357.02K
Shares Held After
52,712
% of Holdings
1.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
MAHON PAUL A
— EVP & GENERAL COUNSEL
May 21, 2026
Sale
Shares
10
Price
$556.70
Total Value
$5.57K
Shares Held After
53,352
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
MAHON PAUL A
— EVP & GENERAL COUNSEL
May 21, 2026
Sale
Shares
110
Price
$555.72
Total Value
$61.13K
Shares Held After
53,362
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Kalaris Therapeutics, Inc.
(KLRS)
AKKARAJU SRINIVAS
— Director
May 20, 2026
Purchase
Shares
244,300
Price
$4.83
Total Value
$1.18M
Shares Held After
2,224,147
% of Holdings
11.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BioXcel Therapeutics, Inc.
(BTAI)
Mehta Vimal
— Director
May 20, 2026
Sale
Shares
19,419
Price
$1.09
Total Value
$21.11K
Shares Held After
69,598
% of Holdings
21.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BioXcel Therapeutics, Inc.
(BTAI)
Rodriguez Javier
— Chief Legal Officer, Senior Vice President and Corporate Secretary
May 20, 2026
Sale
Shares
6,560
Price
$1.08
Total Value
$7.11K
Shares Held After
26,803
% of Holdings
19.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BioXcel Therapeutics, Inc.
(BTAI)
Yocca Frank
— Chief Scientific Officer
May 20, 2026
Sale
Shares
6,845
Price
$1.08
Total Value
$7.43K
Shares Held After
26,175
% of Holdings
20.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BioXcel Therapeutics, Inc.
(BTAI)
Steinhart Richard I
— Chief Financial Officer
May 20, 2026
Sale
Shares
6,845
Price
$1.08
Total Value
$7.43K
Shares Held After
26,300
% of Holdings
20.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GYRE THERAPEUTICS, INC.
(GYRE)
Ye Weiguo
— Chief Operating Officer
May 20, 2026
Sale
Shares
9,400
Price
$6.15
Total Value
$57.81K
Shares Held After
700,000
% of Holdings
1.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CASTLE BIOSCIENCES INC
(CSTL)
MAETZOLD DEREK J
— Director
May 20, 2026
Sale
Shares
66
Price
$20.00
Total Value
$1.32K
Shares Held After
2,158
% of Holdings
3.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CASTLE BIOSCIENCES INC
(CSTL)
MAETZOLD DEREK J
— Director
May 20, 2026
Sale
Shares
66
Price
$20.00
Total Value
$1.32K
Shares Held After
2,158
% of Holdings
3.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CASTLE BIOSCIENCES INC
(CSTL)
MAETZOLD DEREK J
— Director
May 20, 2026
Sale
Shares
66
Price
$20.00
Total Value
$1.32K
Shares Held After
2,158
% of Holdings
3.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CASTLE BIOSCIENCES INC
(CSTL)
MAETZOLD DEREK J
— Director
May 20, 2026
Sale
Shares
66
Price
$20.00
Total Value
$1.32K
Shares Held After
2,158
% of Holdings
3.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CASTLE BIOSCIENCES INC
(CSTL)
MAETZOLD DEREK J
— Director
May 20, 2026
Sale
Shares
273
Price
$20.00
Total Value
$5.46K
Shares Held After
38,941
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CASTLE BIOSCIENCES INC
(CSTL)
MAETZOLD DEREK J
— Director
May 20, 2026
Sale
Shares
322
Price
$20.00
Total Value
$6.44K
Shares Held After
45,816
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CASTLE BIOSCIENCES INC
(CSTL)
MAETZOLD DEREK J
— Director
May 20, 2026
Sale
Shares
130
Price
$20.00
Total Value
$2.60K
Shares Held After
21,479
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Dyne Therapeutics, Inc.
(DYN)
Posner Brian S
— Director
May 20, 2026
Purchase
Shares
2,500
Price
$17.12
Total Value
$42.80K
Shares Held After
18,000
% of Holdings
13.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
REGIONAL HEALTH PROPERTIES, INC
(RHEP)
Morrison Brent
— Director
May 20, 2026
Purchase
Shares
5,000
Price
$1.27
Total Value
$6.35K
Shares Held After
7,272
% of Holdings
68.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ESTABLISHMENT LABS HOLDINGS INC.
(ESTA)
JW Asset Management, LLC
— 10% Owner
May 20, 2026
Sale
Shares
3,580
Price
$70.56
Total Value
$252.60K
Shares Held After
2,998,114
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
EXELIXIS, INC.
(EXEL)
Haley Patrick J.
— EVP, Commercial
May 20, 2026
Sale
Shares
32,110
Price
$49.81
Total Value
$1.60M
Shares Held After
357,638
% of Holdings
8.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Guardant Health, Inc.
(GH)
Talasaz AmirAli
— Director
May 20, 2026
Sale
Shares
26,352
Price
$112.76
Total Value
$2.97M
Shares Held After
1,886,504
% of Holdings
1.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Guardant Health, Inc.
(GH)
Talasaz AmirAli
— Director
May 20, 2026
Sale
Shares
37,900
Price
$112.02
Total Value
$4.25M
Shares Held After
1,912,856
% of Holdings
1.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Guardant Health, Inc.
(GH)
Talasaz AmirAli
— Director
May 20, 2026
Sale
Shares
37,163
Price
$111.14
Total Value
$4.13M
Shares Held After
1,950,756
% of Holdings
1.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Guardant Health, Inc.
(GH)
Talasaz AmirAli
— Director
May 20, 2026
Sale
Shares
28,908
Price
$110.10
Total Value
$3.18M
Shares Held After
1,987,919
% of Holdings
1.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Guardant Health, Inc.
(GH)
Talasaz AmirAli
— Director
May 20, 2026
Sale
Shares
9,852
Price
$108.97
Total Value
$1.07M
Shares Held After
2,016,827
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Guardant Health, Inc.
(GH)
Talasaz AmirAli
— Director
May 20, 2026
Sale
Shares
33,069
Price
$108.11
Total Value
$3.57M
Shares Held After
2,026,679
% of Holdings
1.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Guardant Health, Inc.
(GH)
Talasaz AmirAli
— Director
May 20, 2026
Sale
Shares
21,171
Price
$106.99
Total Value
$2.27M
Shares Held After
2,059,748
% of Holdings
1.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Guardant Health, Inc.
(GH)
Talasaz AmirAli
— Director
May 20, 2026
Sale
Shares
1,200
Price
$105.88
Total Value
$127.05K
Shares Held After
2,080,919
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Guardant Health, Inc.
(GH)
Talasaz AmirAli
— Director
May 20, 2026
Sale
Shares
11,919
Price
$105.01
Total Value
$1.25M
Shares Held After
2,082,119
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Guardant Health, Inc.
(GH)
Talasaz AmirAli
— Director
May 20, 2026
Sale
Shares
1,366
Price
$103.82
Total Value
$141.82K
Shares Held After
2,094,038
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
← Previous
Next →
Showing 401–450 of 5662 transactions (page 9 of 114)
Version: v26.5.2